Hyperbaric oxygen therapy affects insulin sensitivity/resistance by increasing adiponectin, resistin, and plasminogen activator inhibitor-I in rats

Kahraman C., YAMAN H.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.3, ss.1572-1578, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 51 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.3906/sag-2011-76
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1572-1578
  • Anahtar Kelimeler: Adiponectin, insulin, insulin sensitivity, resistin, plasminogen activator inhibitor-I, HIGH-DENSITY-LIPOPROTEIN, CORONARY-HEART-DISEASE, ADIPOSE-TISSUE, GLUCOSE, CHOLESTEROL, OBESITY, RISK, MEN
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background/aim: Hyperbaric oxygen therapy (HBOT) causes insulin sensitivity, but the reason for this is not known yet. The aim of the present study was to investigate the effect of HBOT on insulin sensitivity via resistin, plasminogen activator inhibitor-I (PAI-I), and adiponectin.